Objective: To investigate the relationship between the objective response to combination chemotherapy of taxanes plus cisplatin in non-small cell lung cancer (N
Objective: How to improve the postoperative 5-year survival rate for lung cancer and to give more patients a chance of surgery have become research hotspots. Th